Recruiting

Digital Inhaler

Sponsor:

Cedars-Sinai Medical Center

Code:

NCT07214337

Conditions

Chronic Obstructive Airways Disease Exacerbated

Chronic Obstructive Airway Disease

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Digital Inhaler Attachment

Study Details

Brief summary:

This is a pilot study to evaluate the role digital inhaler technology on patients with obstructive lung disease in preventing admissions and exacerbation, as well as improving symptom control. The primary objective is to evaluate feasibility of study protocol, patient recruitment, and patient retention with goal recruitment of 20 participants, 60% recruitment success, and 60% retention rate for 6 months duration. The secondary objectives are the evaluation of patient admission rate, exacerbation rates, and symptoms control with use of digital inhaler technology The subject population will be patients with physician diagnosed obstructive lung disease.

Conditions

Chronic Obstructive Airways Disease Exacerbated

Chronic Obstructive Airway Disease

Study ID

NCT07214337

Start date

Nov 10, 2026

Status verified date

Nov, 2026

Completion date

Jun, 2027

Anticipated

Primary completion date

Jan, 2027

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • Any sex
  • Over the age of 18 years.
  • Physician-diagnosed obstructive lung disease
  • Speak, read, and understand English.
  • The current study is a feasibility pilot. Based on the results of the study, future studies will include non-English speakers as well.
  • Able to understand study requirements and comply with study procedures.
  • Ability to operate a smartphone or tablet (for questionnaire and symptoms input).
  • Patients who use either a DPI or an MDI device as controller medications. Medications will not be changed by the study team.

Exclusion Criteria:

  • Physically disabled such that they are incapable of using digital devices or metered dose inhalers.
  • Suffer from any visual, hearing or cognitive impairment that cannot be corrected enough to operate the devices properly. Mild/moderate vision loss and mild hearing loss may be included with appropriate corrective measures that do not affect the device usage.
  • Suffering from serious uncontrolled medical conditions that may interfere with study conduct.
  • Inability or unwillingness of the participant to give written informed consent.
  • Pregnant women (due to complicated physiology)
  • The current study is a feasibility pilot. Based on the results of the study, future studies will likely include pregnant patients as well.
  • Prisoners

Study Design

Enrollment

20 participants

Anticipated

Intervention Model

Single group

Primary purpose

Other

Interventions and Outcome Measures

Arms

other: Digital Inhaler Attachment for Regular Care

This group of patients will be provided interactive device that provides inhaler coaching for to use for 6 month duration.

Interventions

Digital Inhaler Attachment

This intervention is the attachment of a digital device to provide patient with coaching for optimal inhaler use and technique, as well as monitoring of patient use of inhaler to patient and health care team. Patient will continue to use inhalers prescribed as per usual care for management of COPD.

Primary outcome measure

  • Participant Recruitment Percentage [ Time Frame: 6 months ]
  • Participant Retention Percentage [ Time Frame: 6 months ]

Central Contacts and Locations

Central contacts

Vinita Kusupati, MD

14016512622vinita.kusupati@cshs.org

Sara Ghandehari, MD

sara.ghandehari@cshs.org

Locations

Cedars-Sinai Medical Center

Recruiting

Los Angeles, California, United States, 90048

Contacts

Vinita Kusupati

4016512622vinita.kusupati@cshs.org

Principal Investigator:

Sara Ghandehari, MD

More Information

Sponsor

Cedars-Sinai Medical Center

Last update posted

Nov 12, 2026

Last verified

Nov, 2026

Keywords

  • Chronic Obstructive Airways Disease
  • COPD
  • COPD Exacerbation
  • Severe COPD
  • Moderate COPD
  • Severe Chronic Obstructive Airways Disease
  • Moderate Chronic Obstructive Airways Disease

Trial information was received from ClinicalTrials.gov and was last updated on 2026-11-13. This information was provided to ClinicalTrials.gov by Cedars-Sinai Medical Center on 2026-11-12. Recruitment status is synced daily from ClinicalTrials.gov and may not reflect the sponsor's current status. Confirm during your call.